X

Earnings Summary: Builders FirstSource (BLDR) Q4 FY25 sales decline 12%

Builders FirstSource, Inc. (NYSE: BLDR), a leading supplier of structural building products and prefabricated components, reported a double-digit decrease in…

Orion Engineered Carbons Confronts Cycle Lows With Cost Reset and Disciplined 2026 Outlook

Orion Engineered Carbons S.A. (NYSE: OEC) is a Luxembourg-based global supplier of specialty and rubber carbon black serving tire, coatings,…

MITT Solidifies Market Position with Arc Home Expansion and Disciplined Securitization

TPG Mortgage Investment Trust, Inc. (NYSE: MITT), with a market capitalization of approximately $0.29 billion, is a residential mortgage real estate…

Energy Transfer LP Announces Record Full-Year 2025 Results and Increased 2026 Guidance

Energy Transfer LP (NYSE: ET) today reported financial and operational results for the fourth quarter and fiscal year ended December…

DFIN’s Software Pivot Pays Off: High Margins and Recurring Revenue Lead the Way

Donnelley Financial Solutions Inc (NYSE: DFIN), a provider of regulatory compliance, financial technology, and risk management solutions, had a market…

Cardiovascular and Robotics Drive Medtronic’s Record 10-Quarter Revenue Spike

Medtronic PLC (NYSE: MDT) is a Dublin-based global medical technology company with a market capitalization of approximately $110 billion. The…

CNH Industrial Beats Q4 Estimates but Braces for 2026 Industry Trough

CNH Industrial NV (NYSE: CNH) reported fourth-quarter 2025 financial results on Tuesday that exceeded Wall Street expectations, driven by strong…

Tower Semiconductor Q4 2025 Drives Record Revenue and Aggressive CapEx Expansion

Tower Semiconductor (NASDAQ: TSEM, TASE: TSEM) delivered a standout performance for the fourth quarter ended December 31, 2025, reporting record…

NeoGenomics Full Year 2025 Revenue Rises to $727 Million

NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter and full…

Krystal Biotech Surpasses Expectations as VYJUVEK Drives Record 2025 Revenue and International Expansion

Krystal Biotech, Inc. (NASDAQ: KRYS), a leader in redosable gene therapies, today announced record-breaking financial results for the fourth quarter…